STAGE IIIA BLADDER CANCER AJCC V8
Clinical trials for STAGE IIIA BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy aims to tame immunotherapy side effects in advanced cancers
Disease control OngoingThis study tests whether adding tocilizumab to two standard immunotherapy drugs (ipilimumab and nivolumab) can reduce severe side effects while still fighting cancer. About 35 adults with advanced melanoma, non-small cell lung cancer, or bladder cancer will receive the combinatio…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:46 UTC
-
Immunotherapy boost may help bladder cancer patients avoid surgery
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemoradiation helps people with muscle-invasive bladder cancer live longer without their cancer returning. About 475 adults with localized disease that hasn't spread are taking part. The goal is to s…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC
-
Bladder cancer survivors: how does treatment change your daily life?
Knowledge-focused OngoingThis study follows 204 people with bladder cancer to see how their treatment (surgery or radiation) affects their quality of life. Participants fill out surveys about physical function, pain, fatigue, mood, and bladder, bowel, and sexual health. The goal is to understand the real…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 05:37 UTC
-
Can a gene test tell who will respond to immunotherapy?
Knowledge-focused OngoingThis study looks at whether certain genetic changes in tumors can help predict if the immunotherapy drug nivolumab will work for people with advanced bladder cancer that has spread. Researchers are testing tumor samples for specific gene mutations and a protein called CXCL13. The…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 05:36 UTC